Market News AIOpen the app

Quest Diagnostics shares what happened during their earnings call for the third quarter of 2026.

ResultsRead the original at Benzinga
Good for DGX

Quest Diagnostics grew sales and adjusted profit, gained testing volume, and raised its full-year forecast. Lower sales per order and concerns about 2027 lab payment rates are risks, but the growth and higher forecast carry more weight.

DGX · Quest Diagnostics

AI read · Good for DGX

The AI's read

More testing demand and savings from automation are helping Quest grow. Its physician, hospital, and consumer channels all contributed, and new partnerships add opportunities. Sales per order fell as the mix of business changed, and Quest raised concerns about how lab payment rates will be set in 2027. Those risks temper the picture, but the growth and higher full-year forecast carry more weight.

Get alerts for DGX

Follow Quest Diagnostics (DGX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DGX
Free on the App Store and Google Play, or on the web.